PBAC Public Summary Documents - November 2007

Public summary documents relating to the November 2007 PBAC meeting

• Abatacept, powder for I.V. infusion, 250 mg, Orencia®
• ADALIMUMAB, 40 mg in 0.8 mL pre-filled syringe, packs of 2 and 6, Humira®, ADALIMUMAB PEN, 40 mg solution in 0.8 mL pre-filled pen, packs of 2 and 6, Humira Pen®
• ADEFOVIR DIPIVOXIL, tablet, 10 mg, Hepsera®
• Cinacalcet hydrochloride, tablets, 30 mg, 60 mg and 90mg, Sensipar®
• Clostridium botulinum type A toxin-haemagglutinin complex, lyophilised powder for I.M. injection, 500 units/vial, Dysport®
• Darbepoetin alfa, injection, 200 micrograms/0.4 mL, 300 micrograms/0.6 mL and 500 micrograms/1 mL, Aranesp® and Aranesp SureClick®
• Erlotinib hydrochloride, film-coated tablets, 25 mg, 100 mg and 150 mg (base), Tarceva®
• Fentanyl citrate, lozenge with integral applicator, 200 microgram, 400 microgram, 600 microgram, 800 microgram, 1200 microgram and 1600 microgram, Actiq®
• Human Papillomavirus (Types 16 and 18) recombinant, AS04 adjuvanted vaccine, injection, 0.5 ml vial and pre-filled syringe, Cervarix®
• IDURSULFASE-rhu, concentrate for intravenous solution for infusion, 6 mg/3 mL, Elaprase®
• INFLUENZA VACCINE, injection, 0.5 mL, Fluarix®, Fluvax®, Influvac®, Vaxigrip®
• Insulin detemir, cartridge 3mL, prefilled device 3 mL, prefilled syringe 3 mL, 100 U/mL, Levemir®
• Ivabradine hydrochloride, film coated tablets, 5 mg and 7.5 mg, Coralan®
• Lapatinib ditosylate, tablets, 250 mg, Tykerb®
• MACROGOL 3350 plus electrolytes, sachets containing powder for solution, 13.125 g and 6.563 g, Movicol®, Movicol®-Half
• MEASLES, MUMPS, RUBELLA and VARICELLA VACCINE, powder for injection vial with diluent syringe, 0.5 mL, Priorix-Tetra®
• Natalizumab, concentrated solution for IV infusion, 300 mg per 15 mL, Tysabri®
• PALIPERIDONE, prolonged release tablets, 3mg, 6 mg, 9 mg, 12 mg, Invega®
• Pemetrexed disodium, injection, 500 mg, Alimta®,
• Pioglitazone hydrochloride, tablet, 15 mg, 30 mg and 45 mg, Actos®
• ROSIGLITAZONE MALEATE, tablet, 4 mg (base) and 8 mg Avandia®; and ROSIGLITAZONE MALEATE with METFORMIN HYDROCHLORIDE, 2 mg (base) – 500 mg, 2 mg (base) – 1 g, 4 mg (base) – 500 mg and 4 mg (base) – 1 g, Avandamet®
• TACROLIMUS, capsules, 500 micrograms, 1 mg and 5 mg, Prograf®
• TERBINAFINE, tablet, 250 mg and cream, 10 mg per g (1%), 15 g, Lamisil®
• Zonisamide, capsule, 25, 50 and 100 mg, Zonegran®
• ZOSTER VIRUS VACCINE LIVE (Oka/Merk), injection, 0.65 mL, Zostavax®

Page last updated: 29 February 2008